ESR partners with GE HealthCare to focus on breast cancer treatment

The European Society of Radiology (ESR) is renewing its collaboration with GE HealthCare, with the organizations set to showcase their combined work in oncology, cardiology, and neurology at this year’s European Congress of Radiology conference (ECR 2024), held Feb. 28 to March 3 in Vienna. 

In a statement, GE said it will be emphasizing its commitment to utilizing imaging to advance precision care initiatives, in line with the ECR 2024 theme of “Next Generation Radiology.”

The president of the ESR, Carlo Catalano, PhD will be hosting a session on Feb. 28 alongside Elie Chaillot, President and CEO of GE HealthCare International, to delve into the “care pathways” approach to achieving better patient care through precision diagnosis of medical conditions. Specifically, GE said it will be focusing on breast cancer and women’s health as a guiding example of tailoring treatment based on a patient’s unique physiology and diagnosis.

“We are excited about the continuation of our collaboration with the European Society of Radiology for the latest edition of ECR. Our innovations aim to bring healthcare to the next level by creating insights for better, more targeted, and more individualized patient care,” Chaillot said in the statement. The collaboration between industry, academia, healthcare professionals and patient groups is critical in this journey to improve patient outcomes and drive the future of healthcare.”

ECR 2024 will feature the launch of a mobile screening system that will allow women of all ages to undergo breast imaging regardless of their location.

Those looking to attend the conference can register by clicking here.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.